Organovo has just released an 8K filing detailing the fact that they have teamed with a Pharmaceutical company owned by pharm giant Johnson & Johnson, called Janssen Research and Development. The agreement which was signed will have both Organovo & Janssen Research and Development (JRD) work together to evaluate the use of 3D bio-printing in the drug discovery and testing setting. More details on this agreement can be found here: http://3dprint.com/10171/organovo-johnson-johnson/

Will this be the spark that ignites the 3D bio-printing fire? Opinions?